Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06568978
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
Evaluation of Respiratory Parameters in Patients With Upper Limb Lymphedema
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Disease Severity Respiratory Muscle Strength Respiratory Functions Functionality and Quality of Life in Patients With Upper Limb Lymphedema
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of our study is to assess disease severity respiratory muscle strength respiratory functions pectoralis minor muscle shortening functionality and quality of life QoL in patients with upper limb lymphedema ULL and to compare these findings with healthy controlsThe disease severity was assessed using the Stillwell classification system respiratory muscle strength was measured through maximum inspiratory and expiratory intraoral pressures MIP MEP respectively respiratory functions were evaluated with a spirometer pectoralis minor muscle shortening was measured with a tape measure functionality was assessed using the Disabilities of the Arm Shoulder and Hand DASH and QoL was evaluated with the Lymphedema Quality of Life Questionnaire - Arm LYMQOL-Arm
Detailed Description:
The study had a cross-sectional observational study design The participants were divided into two groups patients with ULL in Group 1 the healthy individuals were included in Group 2 All assessments for both groups were performed by two different physiotherapists
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None